<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1093/ofid/ofz036</dc:identifier><dc:language>eng</dc:language><dc:creator>Mendoza, Carmen de</dc:creator><dc:creator>Pirón, María</dc:creator><dc:creator>González, Rocío</dc:creator><dc:creator>Jiménez, Ana</dc:creator><dc:creator>Caballero, Estrella</dc:creator><dc:creator>Roc, Lourdes</dc:creator><dc:creator>Benito, Rafael</dc:creator><dc:creator>Ramos, José Manuel</dc:creator><dc:creator>Soriano, Vicente</dc:creator><dc:title>Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain</dc:title><dc:identifier>ART-2019-111336</dc:identifier><dc:description>Background: although only 8%-10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late diagnoses. Methods: a nationwide HTLV-1 register was created in Spain in 1989. A total of 351 infected persons had been reported by the end of 2017. We examined all new HTLV-1 diagnoses during the last decade and compared their clinical presentation. Results: a total of 247 individuals with HTLV-1 infection had been reported in Spain since year 2008. The incidence has remained stable with 20-25 new diagnoses yearly. Women represented 62%. Only 12% were native Spaniards, most of whom were foreigners from Latin America (72.5%). Up to 57 (23%) individuals presented clinically with HTLV-1-associated conditions, including subacute myelopathy (n = 24; 42.1%), T-cell lymphoma (n = 19; 33.3%), or Strongyloides stercoralis infestation (n = 8; 14%). Human T-cell leukemia virus type 1 diagnosis had been made either at blood banks (n = 109; 44%) or at clinics (n = 138; 56%). It is interesting to note that Spaniards and especially Africans were overrepresented among patients presenting with HTLV-1-associated illnesses, suggesting that misdiagnosis and late presentation are more frequent in these populations compared to Latin Americans. Conclusions: given that 23% of new HTLV-1 diagnoses in Spain are symptomatic, underdiagnosis must be common. Although screening in blood banks mostly identifies asymptomatic Latin American carriers, a disproportionately high number of Spaniards and Africans are unveiled too late, that is, they already suffer from classic HTLV-1 illnesses.</dc:description><dc:date>2019</dc:date><dc:source>http://zaguan.unizar.es/record/79057</dc:source><dc:doi>10.1093/ofid/ofz036</dc:doi><dc:identifier>http://zaguan.unizar.es/record/79057</dc:identifier><dc:identifier>oai:zaguan.unizar.es:79057</dc:identifier><dc:identifier.citation>Open Forum Infectious Diseases 6, 2 (2019), ofz036 [4 pp]</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>